Related Experiment Video
Updated: Feb 15, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
Insights into future therapeutics for atopic dermatitis.
Taylor Edwards1, Nupur U Patel1, Amy Blake1
1a Center for Dermatology Research, Department of Dermatology , Wake Forest School of Medicine , Winston-Salem , NC , USA.
Novel targeted therapies for atopic dermatitis (AD) are advancing through clinical trials. This review examines small molecule and other agents in phase II and III, offering hope for improved AD treatment algorithms.
Area of Science:
- Dermatology
- Pharmacology
- Clinical Trials
Background:
- Atopic dermatitis (AD) is a prevalent chronic inflammatory skin condition.
- Current treatment options for AD are diverse, with ongoing research into novel therapeutic agents.
Purpose of the Study:
- To review small molecule therapies and novel agents for atopic dermatitis in clinical development.
- Focus on therapies in phase II and III clinical trials.
Main Methods:
- Literature search of PubMed and ClinicalTrials.gov.
- Compilation and assessment of clinical trial evidence for novel AD agents.
Main Results:
- Multiple novel topical and oral therapies targeting AD pathogenesis are under investigation.
- Agents include phosphodiesterase-4 inhibitors, boron molecules, Janus kinase inhibitors, and cannabinoid/kappa-opioid receptor agonists.
- Compounds with unknown mechanisms of action are also being studied.
Conclusions:
- Further clinical trials are necessary to fully understand these targeted therapies for AD.
- Successful development of targeted therapies for AD is anticipated, given their efficacy in other inflammatory diseases.
Related Concept Videos
Therapeutic Index
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Microorganisms in Medicine and Therapeutics
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Skeletal Muscle Relaxants: Therapeutic Uses

